Market revenue in 2023 | USD 1,611.7 million |
Market revenue in 2030 | USD 2,481.3 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 69.87% in 2023. Horizon Databook has segmented the Sweden active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmaceutical market in Sweden is highly regulated and characterized by a strong emphasis on patient safety and access to innovative medicines. The country has a universal healthcare system, which means that the government plays a significant role in the pricing and reimbursement of pharmaceutical products.
In recent years, the government in Sweden implemented various measures to control healthcare costs, including introducing reference pricing and using Health Technology Assessments (HTA) to evaluate the new drugs’ value. These measures ensure the healthcare system can provide costeffective treatments to its population.
In addition, Sweden strongly focuses on promoting generic medicines to reduce healthcare expenditures. This creates an opportunity for the generic API manufacturers to ramp up the supply and increase the production of generic drugs. Companies such as Cambrex have facilities in the region that provide generic and innovative API.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Sweden active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account